Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer

NCT00002777 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

342

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: exemestane
DRUG: tamoxifen citrate

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC